• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume9, Issue7

A Comparative Assessment of Safety, Efficacy And Cost Effectiveness Of Glipizide-Metformin And Glimepiride-Metformin Combination Therapy In Type-2 Diabetes Mellitus

    Mina Shahraki Mohammadi , Manouchehr Khanipour

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 9348-9353

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Diabetes mellitus (DM) is defined as a chronic and metabolic disorder. It was approximated about 77 million Indians suffer from DM and it will be increased to 134 million by 2045. Diabetic mellitus can be treated by close control of glucose level which is main aim and target in management of this condition. Management of DM can be done by non-pharmacological and pharmacological approaches. The aim of this study is to compare the safety, efficacy and cost effectiveness of Glipizide-Metformin and Glimepiride-Metformin combination therapy in type 2 diabetes mellitus. In current research by use of prospective method in the cardiology department of Kongunad Multi-speciality Hospital, Coimbatore, in a period of six months from February 2021 to August 2021 we did research according to our aim and used ANOVA statistical test whenever it needed. Our study results demonstrate, the improvement in the addition of glimipride 2mg to metformin 500 mg has modest beneficial then glipizide 5 mg in terms of efficacy and cost. In terms of safety, both drugs are having similar safety profiles. Current research also assessed the medication safety by using the Naranjo scale
Keywords:
    diabetes mellitus anti-diabetic medication hyperglycemia medication safety
  • PDF (331 K)
  • XML
(2023). A Comparative Assessment of Safety, Efficacy And Cost Effectiveness Of Glipizide-Metformin And Glimepiride-Metformin Combination Therapy In Type-2 Diabetes Mellitus. European Journal of Molecular & Clinical Medicine, 9(7), 9348-9353.
Mina Shahraki Mohammadi , Manouchehr Khanipour. "A Comparative Assessment of Safety, Efficacy And Cost Effectiveness Of Glipizide-Metformin And Glimepiride-Metformin Combination Therapy In Type-2 Diabetes Mellitus". European Journal of Molecular & Clinical Medicine, 9, 7, 2023, 9348-9353.
(2023). 'A Comparative Assessment of Safety, Efficacy And Cost Effectiveness Of Glipizide-Metformin And Glimepiride-Metformin Combination Therapy In Type-2 Diabetes Mellitus', European Journal of Molecular & Clinical Medicine, 9(7), pp. 9348-9353.
A Comparative Assessment of Safety, Efficacy And Cost Effectiveness Of Glipizide-Metformin And Glimepiride-Metformin Combination Therapy In Type-2 Diabetes Mellitus. European Journal of Molecular & Clinical Medicine, 2023; 9(7): 9348-9353.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 32
  • PDF Download: 37
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus